We are live on
!
Find out more
AP
Antipodes Partners Portfolio holdings
AUM
$5.19B
1-Year Est. Return
36.17%
This Fund
S&P 500
This Quarter
Est. Return
+6.51%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$155M
(+7.7%)
Cap. Flow
+$46.4M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
63.07%
Holding
32
New
4
Increased
13
Reduced
9
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$118M |
| 2 |
Yum China
YUMC
|
+$104M |
| 3 |
FedEx
FDX
|
+$90.6M |
| 4 |
Alibaba
BABA
|
+$81.6M |
| 5 |
Gilead Sciences
GILD
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Range Resources
RRC
|
+$80.1M |
| 2 |
JD.com
JD
|
+$76.9M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$74.4M |
| 4 |
Intel
INTC
|
+$71.7M |
| 5 |
CNX Resources
CNX
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Consumer Discretionary | 21.41% |
| 3 | Industrials | 17.02% |
| 4 | Healthcare | 12.39% |
| 5 | Communication Services | 10.13% |
Similar funds
MS
AUB
KACA
DDC
MIM
AAI
SCM
SDIC
Antipodes Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Antipodes Partners held 32 positions worth $2.18B, up 7.7% from $2.02B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Antipodes Partners's Q2 2019 filing shows 4 new, 13 increased, 9 reduced and 5 closed positions. Its largest new stake was Merck: 1,535,293 shares worth $123M. The largest sale was Range Resources, an estimated $80.1M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Antipodes Partners's largest Q2 2019 buy was Merck: 1,535,293 shares worth $123M.
- Antipodes Partners added most to Yum China in Q2 2019, an estimated $104M increase.
- Antipodes Partners's biggest Q2 2019 reduction was JD.com, cutting an estimated $76.9M.
- Antipodes Partners fully exited Range Resources in Q2 2019, selling an estimated $80.1M.
- Antipodes Partners's ten largest holdings make up 63% of its $2.18B portfolio in Q2 2019.
- Antipodes Partners opened 4 new positions and closed 5 in Q2 2019.
- Antipodes Partners's portfolio value rose 7.7% quarter-over-quarter to $2.18B.
Based on Antipodes Partners's 13F filing for Q2 2019, filed 14 Aug 2019.